2-Tiered antibody testing for early and late lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test

Clinical Infectious Diseases

Volumn 50, Issue 1, 2010, Pages 20-26

  Branda, John A ^a   Aguero Rosenfeld, Maria E ^b   Ferraro, Mary Jane ^a   Johnson, Barbara J B ^c   Wormser, Gary P ^b   Steere, Allen C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ALGORITHM; ANTIBODY RESPONSE; ARTHRITIS; ARTICLE; BORRELIA INFECTION; CARDITIS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ERYTHEMA CHRONICUM MIGRANS; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LYME DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ALGORITHMS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPROTEINS; LYME DISEASE; MASSACHUSETTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEROTYPING;

EID: 72049106967     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/648674     Document Type: Article

References (24)

1. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43:1089-1134
2. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995; 44:590-591
3. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005; 18:484-509.
4. Steere AC, McHugh G, Damle N, Sikand VK. Prospective study of serologic tests for Lyme disease. Clin Infect Dis 2008; 47:188-195 (Pubitemid 351920619)
5. Feder HM Jr., Johnson BJ, O'Connell S, et al. A critical appraisal of "chronic Lyme disease." N Engl J Med 2007; 357:1422-1430
6. Weinstein A. Laboratory testing for Lyme disease: time for a change? Clin Infect Dis 2008; 47:196-197
7. Johnson BJ, Robbins KE, Bailey RE, et al. Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J Infect Dis 1996; 174:346-353
8. Wormser GP, Horowitz HW, Dumler JS, Schwartz I, Aguero-Rosenfeld M. False-positive Lyme disease serology in human granulocytic ehrlichiosis. Lancet 1996; 347:981-982 (Pubitemid 26102584)
9. Sivak SL, Aguero-Rosenfeld ME, Nowakowski J, Nadelman RB, Wormser GP. Accuracy of IgM immunoblotting to confirm the clinical diagnosis of early Lyme disease. Arch Intern Med 1996; 156:2105-2109 (Pubitemid 26346969)
10. Trevejo RT, Krause PJ, Sikand VK, et al. Evaluation of two-test serodiagnostic method for early Lyme disease in clinical practice. J Infect Dis 1999; 179:931-938 (Pubitemid 29159339)
11. Porwancher R. A reanalysis of IgM Western blot criteria for the diagnosis of early Lyme disease. J Infect Dis 1999; 179:1021-1024 (Pubitemid 29159352)
12. Lawrenz MB, Hardham JM, Owens RT, et al. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol 1999; 37:3997-4004.
13. Bacon RM, Biggerstaff BJ, Schriefer ME, et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 2003; 187:1187-1199
14. Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J Clin Microbiol 1999; 37:3990-3996
15. Mogilyansky E, Loa CC, Adelson ME, Mordechai E, Tilton RC. Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease. Clin Diagn Lab Immunol 2004; 11:924-929 (Pubitemid 39280600)
16. Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme disease-United States, 1992-2006. MMWR Surveill Summ 2008; 57:1-9.
17. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 1996; 34:1-9.
18. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-845
19. Binnicker MJ, Jespersen DJ, Harring JA, Rollins LO, Bryant SC, Beito EM. Evaluation of two commercial systems for automated processing, reading, and interpretation of Lyme borreliosis Western blots. J Clin Microbiol 2008; 46:2216-2221
20. Kannian P, McHugh G, Johnson BJ, Bacon RM, Glickstein LJ, Steere AC. Antibody responses to Borrelia burgdorferi in patients with antibiotic- refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis. Arthritis Rheum 2007; 56:4216-4225
21. Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med 1998; 128:354-362 (Pubitemid 28103103)
22. Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA 1993; 269:1812-1816
23. Jansson C, Carlsson SA, Granlund H, Wahlberg P, Nyman D. Analysis of Borrelia burgdorferi IgG antibodies with a combination of IgG ELISA and VlsE C6 peptide ELISA. Clin Microbiol Infect 2005; 11:147-150
24. Nyman D, Willen L, Jansson C, Carlsson SA, Granlund H, Wahlberg P. VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area. Clin Microbiol Infect 2006; 12:496-497